Literature DB >> 7790426

Evaluation of CMV-vue antigenemia assay for rapid detection of cytomegalovirus in mixed-leukocyte blood fractions.

A Erice1, M A Holm, M V Sanjuan, D L Dunn, P C Gill, H H Balfour.   

Abstract

The CMV-vue antigenemia assay was evaluated by using mixed-leukocyte (ML) blood fractions. Of 234 ML fractions studied, 32 (14%), 23 (10%), and 20 (8.5%) were positive in the CMV-vue assay and conventional and shell vial cultures, respectively. The CMV-vue assay was more sensitive than shell vial cultures for rapid detection of cytomegalovirus. ML fractions are appropriate specimens for the cytomegalovirus antigenemia assay.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7790426      PMCID： PMC228089          DOI： 10.1128/jcm.33.4.1014-1015.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  Optimizing recovery of cytomegalovirus in the shell vial culture procedure.

Authors:  M Arens; J Owen; C M Hagerty; C A Reed; G A Storch
Journal:  Diagn Microbiol Infect Dis       Date:  1991 Mar-Apr       Impact factor: 2.803

2.  Detection of cytomegalovirus infections in specimens other than urine by the shell vial assay and conventional tube cell cultures.

Authors:  C V Paya; A D Wold; T F Smith
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

3.  Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes.

Authors:  A Erice; M A Holm; P C Gill; S Henry; C L Dirksen; D L Dunn; R P Hillam; H H Balfour
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

4.  Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients.

Authors:  R S Buller; T C Bailey; N A Ettinger; M Keener; T Langlois; J P Miller; G A Storch
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948
  4 in total
  5 in total

1.  Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation.

Authors:  I G Sia; J A Wilson; M J Espy; C V Paya; T F Smith
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Comparison of two leukocyte extraction methods for cytomegalovirus antigenemia assay.

Authors:  A García; J Niubò; M A Benítez; M Viqueira; J L Pérez
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay.

Authors:  N Veal; C Payan; D Fray; L Sarol; O Blanchet; S Kouyoumdjian; F Lunel
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

Review 4.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 5.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.